Evidence map›Paper›PMID 38338456›Full record

ArticleMolecules (Basel, Switzerland)2024

MCC950 Ameliorates Diabetic Muscle Atrophy in Mice by Inhibition of Pyroptosis and Its Synergistic Effect with Aerobic Exercise.

Xiaoyu Yan, Pengyu Fu, Yimin Zhang, Dongmei Ling, Lewis Reynolds, Weicheng Hua, Zhiyuan Wang, Fangyuan Ma, Boxuan Li, Jingjing Yu and 3 more

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 3 countries.

Xiaoyu YanKey Laboratory of Exercise and Physical Fitness of Ministry of Education, Beijing Sport University, Beijing 100084, China.
Pengyu FuSchool of Sport Science, Beijing Sport University, Beijing 100084, China.
Yimin ZhangKey Laboratory of Exercise and Physical Fitness of Ministry of Education, Beijing Sport University, Beijing 100084, China.
Dongmei LingSchool of Sport Science, Beijing Sport University, Beijing 100084, China.
Lewis ReynoldsDepartment of Clinical Sciences in Malmö, Lund University Diabetes Centre, Lund University, 21428 Malmö, Sweden.
Weicheng HuaSchool of Sport Science, Beijing Sport University, Beijing 100084, China.
Zhiyuan WangSchool of Sport Science, Beijing Sport University, Beijing 100084, China.
Fangyuan MaSchool of Sport Science, Beijing Sport University, Beijing 100084, China.
Boxuan LiSchool of Sport Science, Beijing Sport University, Beijing 100084, China.
Jingjing YuKey Laboratory of Exercise and Physical Fitness of Ministry of Education, Beijing Sport University, Beijing 100084, China.
Yujia LiuSchool of Sport Science, Beijing Sport University, Beijing 100084, China.ORCID 0000-0001-6261-9827
Lijing GongKey Laboratory of Exercise and Physical Fitness of Ministry of Education, Beijing Sport University, Beijing 100084, China.ORCID 0000-0003-3502-0901
Enming ZhangDepartment of Clinical Sciences in Malmö, Lund University Diabetes Centre, Lund University, 21428 Malmö, Sweden.ORCID 0000-0002-0401-4608
Beijing Sport University · CNLund University · SEChinese University of Hong Kong · HKJiangsu Normal University · CNNankai University · CNNorthwestern Polytechnical University · CN

Funding

Crafoord Foundation Dnr 20190514Fundamental Research Funds for the Central Universities of China 2021TD012Swedish Research Council Dnr 2019-01567Swedish Research Council Dnr 2022-01129
6 · The paper itself

Abstract

Diabetic muscle atrophy is an inflammation-related complication of type-2 diabetes mellitus (T2DM). Even though regular exercise prevents further deterioration of atrophic status, there is no effective mediator available for treatment and the underlying cellular mechanisms are less explored. In this study, we investigated the therapeutic potential of MCC950, a specific, small-molecule inhibitor of NLRP3, to treat pyroptosis and diabetic muscle atrophy in mice. Furthermore, we used MCC950 to intervene in the protective effects of aerobic exercise against muscle atrophy in diabetic mice. Blood and gastrocnemius muscle (GAS) samples were collected after 12 weeks of intervention and the atrophic state was assessed. We initially corroborated a diabetic muscle atrophy phenotype in

Indexed as

Diabetes Mellitus, ExperimentalDiabetes Mellitus, Type 2Diabetic NeuropathiesAnimalsExerciseInflammasomesMiceMice, Inbred StrainsMuscular AtrophyNLR Family, Pyrin Domain-Containing 3 ProteinPyroptosisSulfonamidesInflammasomesNLR Family, Pyrin Domain-Containing 3 ProteinSulfonamidesaerobic exercisediabetesMCC950muscle atrophyNLRP3pyroptosis

Identifiers

PMID38338456
PMCPMC10856337
OpenAlexW4391575420

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.